IP Library Granted Patent US 7,387,803
Granted Patent B2
US 7,387,803 · App. 11/046,436 · Granted Jun 17, 2008

Dietary fiber delivery system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,387,803
App. No.
11/046,436
Granted
Jun 17, 2008
Kind
B2
Abstract

A delivery system and method for delivering soluble dietary fibers in a chewable tablet form which is palatable and demonstrates a high degree of consumer acceptability.

Claims (29)

1. A lozenge comprising, as a source of dietary fiber, a water-soluble, non-gelling dietary fiber component, wherein the dietary fiber component is selected from the group consisting of inulin, fructooligosaccharide, hydrolyzed guar, resistant starch, and a combination thereof, and is present in an amount of at least about 50% by weight of the lozenge, and wherein the dietary fiber component, when combined with water to form a 10% by weight solution, has a viscosity at 25° C. of less than 100 centipoise.

2. The lozenge of claim 1 wherein the lozenge is organoleptically pleasing.

3. The lozenge of claim 1 wherein the non-gelling dietary fiber solution has a viscosity at 25° C. of less than 25 centipoise.

4. A lozenge comprising, as a source of dietary fiber, a water-soluble, non-gelling dietary fiber component, wherein the dietary fiber component is selected from the group consisting of inulin, fructooligosaccharide, hydrolyzed guar, resistant starch, and a combination thereof, and is present in an amount of at least about 10% by weight of the lozenge, and wherein the dietary fiber component, when combined with water to form a 10% by weight solution, has a viscosity at 25° C. of less than 100 centipoise.

5. The lozenge of claim 4 wherein the non-gelling dietary fiber solution has a viscosity at 25° C. of less than 25 centipoise.

6. The lozenge of claim 4 wherein the lozenge is organoleptically pleasing.

7. The lozenge of claim 4 , further comprising a component selected from the group consisting of vitamins, minerals, biologics, and a combination thereof.

8. The lozenge of claim 7 wherein the mineral is calcium.

9. The lozenge of claim 7 wherein the biologic is a probiotic microbial mixture.

10. The lozenge of claim 7 wherein the biologic is a probiotic culture.

11. The lozenge of claim 7 wherein the biologic is a bovine immunoglobulin concentrate.

12. The lozenge of claim 11 wherein the bovine immunoglobulin concentrate is selected from the group consisting of a colostrum, a hyper-immune colostrum, and a hyper-immune milk.

13. The lozenge of claim 7 , wherein the biologic is an immunoglobulin.

14. The lozenge of claim 7 wherein the lozenge is organoleptically pleasing.

15. The lozenge of claim 7 , wherein the dietary fiber component is present in an amount of at least about 20% by weight of the lozenge.

16. The lozenge of claim 7 , wherein the dietary fiber component is present in an amount of at least about 30% by weight of the lozenge.

17. The lozenge of claim 7 , wherein the dietary fiber component is present in an amount of at least about 40% by weight of the lozenge.

18. The lozenge of claim 7 , wherein the dietary fiber component is present in an amount of at least about 45% by weight of the lozenge.

19. The lozenge of claim 7 , wherein the dietary fiber component is present in an amount of at least about 50% by weight of the lozenge.

20. The lozenge of claim 4 , further comprising a component selected from the group consisting of vitamins, minerals, biologics, and a combination thereof.

21. The lozenge of claim 20 , wherein the dietary fiber component is present in an amount of at least about 20% by weight of the lozenge.

22. The lozenge of claim 20 , wherein the dietary fiber component is present in an amount of at least about 30% by weight of the lozenge.

23. The lozenge of claim 20 , wherein the dietary fiber component is present in an amount of at least about 40% by weight of the lozenge.

24. The lozenge of claim 20 , wherein the dietary fiber component is present in an amount of at least about 45% by weight of the lozenge.

25. The lozenge of claim 20 , wherein the dietary fiber component is present in an amount of at least about 50% by weight of the lozenge.

26. The lozenge of claim 4 , wherein the dietary fiber component is present in an amount of at least about 20% by weight of the lozenge.

27. The lozenge of claim 4 , wherein the dietary fiber component is present in an amount of at least about 30% by weight of the lozenge.

28. The lozenge of claim 4 , wherein the dietary fiber component is present in an amount of at least about 45% by weight of the lozenge.

29. A lozenge comprising, as a source of dietary fiber, a water-soluble, non-gelling dietary fiber component, wherein the dietary fiber component is selected from the group consisting of inulin, fructooligosaccharide, hydrolyzed guar, resistant starch, and a combination thereof, and is present in an amount of at least about 40% by weight of the lozenge, and wherein the dietary fiber component, when combined with water to form a 10% by weight solution, has a viscosity at 25° C. of less than 100 centipoise.

Assignments (7)
PARTIAL RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: CITIBANK, N.A.
To: BLACKSMITH BRANDS, INC.; MEDTECH PRODUCTS, INC.
Reel/Frame 048608/0286 →
PARTIAL RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: BARCLAYS BANK PLC (AS SUCCESSOR IN INTEREST TO CITIBANK, N.A.)
To: BLACKSMITH BRANDS, INC.; MEDTECH PRODUCTS, INC.
Reel/Frame 048608/0386 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 26, 2017
From: CITIBANK, N.A., AS PRIOR AGENT
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 041504/0208 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2016
From: MEDTECH PRODUCTS INC.
To: MOBERG PHARMA AB
Reel/Frame 039137/0117 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2012
From: GLAXOSMITHKLINE PLC
To: MEDTECH PRODUCTS INC.
Reel/Frame 027998/0229 →
SECURITY AGREEMENT Recorded Feb 3, 2012
From: BLACKSMITH BRANDS, INC.; MEDTECH PRODUCTS INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 027645/0862 →
SECURITY AGREEMENT Recorded Feb 2, 2012
From: BLACKSMITH BRANDS, INC.; MEDTECH PRODUCTS INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 027645/0743 →